Orchestra BioMed Holdings, Inc. (OBIO) Capital expenditures 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$489,000FY2025 · since FY2022: $591,000 → $489,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $489,000 | +69.2% |
| FY2024 | $289,000 | +270.5% |
| FY2023 | $78,000 | -86.8% |
| FY2022 | $591,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice